Get started
Author

Line Pickering

Observed names: L. Pickering, Line Pickering Boserup, Pickering Boserup, Line
Institution: Lundbeck (Denmark)
ORCID: 0000-0002-3062-8881
Observed ORCID: 0000-0002-3062-8881
OpenAlex ID: A5084364629
Sleep–wake and melatonin pattern in craniopharyngioma patients
2014 · Line Pickering, Poul Jennum, et al. · European Journal of Endocrinology · 73
Morbidity and mortality of middle-aged and elderly narcoleptics
2017 · Poul Jennum, Eva Wiberg Thorstensen, et al. · Sleep Medicine · 41
Morbidity and mortality of childhood- and adolescent-onset epilepsy: A controlled national study
2016 · Poul Jennum, Line Pickering, et al. · Epilepsy & Behavior · 40
Morbidity of childhood onset narcolepsy: a controlled national study
2016 · Poul Jennum, Line Pickering, et al. · Sleep Medicine · 29
Brain tumours result in sleep disorders in children and adolescents
2021 · Line Pickering, Katharina M. Main, et al. · Sleep Medicine · 19
PDF
Long-term health and socioeconomic consequences of childhood and adolescent onset of meningococcal meningitis
2018 · Line Pickering, Poul Jennum, et al. · European Journal of Pediatrics · 19
Systematic Review: Sleep Disorders Based on Objective Data in Children and Adolescents Treated for a Brain Tumor
2022 · Anne Sophie Lind Helligsoe, Kathrine Synne Weile, et al. · Frontiers in Neuroscience · 16
Polysomnographic findings in craniopharyngioma patients
2017 · Line Pickering, Marianne Klose, et al. · Sleep And Breathing · 16
Welfare cost of childhood- and adolescent-onset epilepsy: A controlled national study
2016 · Poul Jennum, Line Pickering, et al. · Epilepsy & Behavior · 14
Diagnostic value of actigraphy in hypersomnolence disorders
2021 · Eva Wiberg Torstensen, Line Pickering, et al. · Sleep Medicine · 13
Brain tumours in children and adolescents may affect the circadian rhythm and quality of life
2021 · Line Pickering, Katharina M. Main, et al. · Acta Paediatrica · 12
Survival and long‐term socioeconomic consequences of childhood and adolescent onset of brain tumours
2022 · Line Pickering, Katharina M. Main, et al. · Developmental Medicine & Child Neurology · 11
PDF
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache
2024 · Andrew Blumenfeld, David Kudrow, et al. · Headache The Journal of Head and Face Pain · 8
Decrease in scale invariance of activity fluctuations with aging and in patients with suprasellar tumors
2017 · S. D. Joustra, C. Gu, et al. · Chronobiology International · 7
PDF
12484 Safety And Pharmacokinetics Of Anti-ACTH Antibody Lu AG13909 In Patients With Classic Congenital Adrenal Hyperplasia: Phase 1 Open-label, Multiple-Ascending-Dose Trial Protocol
2024 · Umasuthan Srirangalingam, Anand Velusamy, et al. · Journal of the Endocrine Society · 5
PDF
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
2024 · Patricia Pozo-Rosich, Messoud Ashina, et al. · Neurology and Therapy · 4
PDF
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
2024 · Anna Gryglas‐Dworak, Jack Schim, et al. · Headache The Journal of Head and Face Pain · 3
PDF
Early and Sustained Shift in Headache Day Frequency Following Eptinezumab Treatment in Adults With Migraine for Whom 2–4 Previous Preventive Treatments Have Failed: A Post Hoc Analysis of the Randomized DELIVER Trial
2025 · Cristina Tassorelli, Amaal J. Starling, et al. · European Journal of Neurology · 2
PDF
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed
2025 · Dimos D. Mitsikostas, Susanne F. Awad, et al. · Advances in Therapy · 2
PDF
Pharmacokinetics and safety of eptinezumab in children and adolescents with migraine
2025 · Andrew D. Hershey, Johan Areberg, et al. · Headache The Journal of Head and Face Pain · 2
PDF
[Sleep and circadian rhythms].
2018 · Line Pickering, Eva Wiberg Thorstensen, et al. · PubMed · 2
Eptinezumab for migraine prevention after other treatments fail: a plain language summary of publications
2025 · Messoud Ashina, Elena Ruiz de la Torre, et al. · Pain Management · 1
PDF
Safety and Tolerability of Anti-PACAP Monoclonal Antibody Lu AG09222 when Co-administered with a Gepant in Participants with Migraine (S37.005)
2026 · Amaal Starling, Jessica Ailani, et al. · Neurology
Long‐Term Improvements Following Initial Migraine Response in Eptinezumab‐Treated Participants With Migraine for Whom 2–4 Prior Preventive Treatments Have Failed
2026 · Jessica Ailani, Messoud Ashina, et al. · European Journal of Neurology
Sustained Efficacy of Eptinezumab in Participants with Migraine for Whom Prior Preventive Treatments Failed and Who Self-reported Psychiatric Comorbidities: Post Hoc Analysis of the Placebo-controlled DELIVER Trial
2026 · Patricia Pozo-Rosich, Cristina Tassorelli, et al. · Neurology and Therapy
PDF
Works count: 27
Citation count: 339
H-index: 11
I10-index: 12
Year
Topic
Type